Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 21633167)

1.

CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice.

Weber C, Meiler S, Döring Y, Koch M, Drechsler M, Megens RT, Rowinska Z, Bidzhekov K, Fecher C, Ribechini E, van Zandvoort MA, Binder CJ, Jelinek I, Hristov M, Boon L, Jung S, Korn T, Lutz MB, Förster I, Zenke M, Hieronymus T, Junt T, Zernecke A.

J Clin Invest. 2011 Jul;121(7):2898-910. doi: 10.1172/JCI44925.

2.

Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets.

Kang S, Xie J, Ma S, Liao W, Zhang J, Luo R.

Immunobiology. 2010;215(2):153-62. doi: 10.1016/j.imbio.2009.03.001. Epub 2009 May 17.

PMID:
19450895
3.

Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.

Subramanian M, Thorp E, Hansson GK, Tabas I.

J Clin Invest. 2013 Jan;123(1):179-88. doi: 10.1172/JCI64617. Epub 2012 Dec 21.

4.

CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell-mediated protection from colitis.

Heiseke AF, Faul AC, Lehr HA, Förster I, Schmid RM, Krug AB, Reindl W.

Gastroenterology. 2012 Feb;142(2):335-45. doi: 10.1053/j.gastro.2011.10.027. Epub 2011 Nov 2.

PMID:
22057112
6.

Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs.

Semmling V, Lukacs-Kornek V, Thaiss CA, Quast T, Hochheiser K, Panzer U, Rossjohn J, Perlmutter P, Cao J, Godfrey DI, Savage PB, Knolle PA, Kolanus W, Förster I, Kurts C.

Nat Immunol. 2010 Apr;11(4):313-20. doi: 10.1038/ni.1848. Epub 2010 Feb 28.

PMID:
20190758
7.

Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions.

Zou T, Caton AJ, Koretzky GA, Kambayashi T.

J Immunol. 2010 Sep 1;185(5):2790-9. doi: 10.4049/jimmunol.0903740. Epub 2010 Aug 4.

8.

CD40 expression levels modulate regulatory T cells in Leishmania donovani infection.

Martin S, Agarwal R, Murugaiyan G, Saha B.

J Immunol. 2010 Jul 1;185(1):551-9. doi: 10.4049/jimmunol.0902206. Epub 2010 Jun 4.

9.

CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype.

Guo Z, Jang MH, Otani K, Bai Z, Umemoto E, Matsumoto M, Nishiyama M, Yamasaki M, Ueha S, Matsushima K, Hirata T, Miyasaka M.

Int Immunol. 2008 Mar;20(3):307-15. doi: 10.1093/intimm/dxm143. Epub 2008 Jan 9.

10.

Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17--a new mechanism of impaired antitumor immunity.

Mishalian I, Bayuh R, Eruslanov E, Michaeli J, Levy L, Zolotarov L, Singhal S, Albelda SM, Granot Z, Fridlender ZG.

Int J Cancer. 2014 Sep 1;135(5):1178-86. doi: 10.1002/ijc.28770. Epub 2014 Feb 27.

PMID:
24501019
11.

Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen.

Alferink J, Lieberam I, Reindl W, Behrens A, Weiss S, Hüser N, Gerauer K, Ross R, Reske-Kunz AB, Ahmad-Nejad P, Wagner H, Förster I.

J Exp Med. 2003 Mar 3;197(5):585-99.

12.

Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.

Zeng M, Guinet E, Nouri-Shirazi M.

Transpl Immunol. 2009 Dec;22(1-2):82-92. doi: 10.1016/j.trim.2009.07.004. Epub 2009 Jul 25.

PMID:
19635560
13.

Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.

Riezu-Boj JI, Larrea E, Aldabe R, Guembe L, Casares N, Galeano E, Echeverria I, Sarobe P, Herrero I, Sangro B, Prieto J, Lasarte JJ.

J Hepatol. 2011 Mar;54(3):422-31. doi: 10.1016/j.jhep.2010.07.014. Epub 2010 Sep 26.

PMID:
21129807
14.

Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice.

Suffner J, Hochweller K, Kühnle MC, Li X, Kroczek RA, Garbi N, Hämmerling GJ.

J Immunol. 2010 Feb 15;184(4):1810-20. doi: 10.4049/jimmunol.0902420. Epub 2010 Jan 18.

15.

Dendritic cell-restricted CD80/86 deficiency results in peripheral regulatory T-cell reduction but is not associated with lymphocyte hyperactivation.

Bar-On L, Birnberg T, Kim KW, Jung S.

Eur J Immunol. 2011 Feb;41(2):291-8. doi: 10.1002/eji.201041169. Epub 2011 Jan 11.

PMID:
21267999
16.

Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function.

Wang Y, Huang G, Vogel P, Neale G, Reizis B, Chi H.

Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):E343-52. doi: 10.1073/pnas.1115635109. Epub 2012 Jan 23.

17.

Dendritic cells in atherosclerosis: evidence in mice and humans.

Zernecke A.

Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):763-70. doi: 10.1161/ATVBAHA.114.303566. Epub 2015 Feb 12. Review.

PMID:
25675999
18.

Dendritic cells in atherogenesis: possible novel targets for prevention of atherosclerosis.

Takeda M, Yamashita T, Sasaki N, Hirata K.

J Atheroscler Thromb. 2012;19(11):953-61. Epub 2012 Aug 9. Review.

19.

Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets.

Fujita H, Shemer A, Suárez-Fariñas M, Johnson-Huang LM, Tintle S, Cardinale I, Fuentes-Duculan J, Novitskaya I, Carucci JA, Krueger JG, Guttman-Yassky E.

J Allergy Clin Immunol. 2011 Sep;128(3):574-82.e1-12. doi: 10.1016/j.jaci.2011.05.016. Epub 2011 Jun 25.

PMID:
21704361
20.

Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells.

Kleijwegt FS, Laban S, Duinkerken G, Joosten AM, Zaldumbide A, Nikolic T, Roep BO.

J Immunol. 2010 Aug 1;185(3):1412-8. doi: 10.4049/jimmunol.1000560. Epub 2010 Jun 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk